Risk factor
Poor trading liquidity
Profitability factor
Favourable analyst view
About
Foresee Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in the United States, China, and Europe. The company's stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-004 that is in preclinical stage to treat opioids use...
Company Valuation
Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. Specifically, the stock is 'cheap' on P/E.
Target Price
The average target price of 6576.TWO is 120 and suggests 50% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell